Physician profile
Sharon E Benson
NPI 1942285556
$745.63
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $311 · 2022: $286 · 2023: $135 · 2024: $13.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $148.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $158.57 | 2021-2023 | |
| Abbott Laboratories | $107.18 | 2022-2023 | Freestyle Libre 2 |
| Amgen INC. | $69.55 | 2021-2022 | |
| Sobi, INC | $66.24 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $42.00 | 2022 | |
| Supernus Pharmaceuticals, INC. | $33.05 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $32.00 | 2021 | |
| Janssen Pharmaceuticals, INC | $31.59 | 2022 | |
| Novo Nordisk INC | $31.09 | 2021-2023 | Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $29.66 | 2021 | |
| Pfizer INC. | $25.21 | 2021-2022 | |
| Amryt Pharma Holdings Ltd | $18.55 | 2021 | |
| Seqirus USA INC | $18.51 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.21 | 2022 | |
| Dexcom, INC. | $14.70 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $13.51 | 2024 | Aristada, Lybalvi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.82 | 2021 | |
| Amarin Pharma, INC. | $12.19 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $12.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Benson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.